Annual Accounts Receivable
$362.00 K
+$106.50 K+41.68%
September 30, 2024
Summary
- As of February 7, 2025, APDN annual accounts receivable is $362.00 thousand, with the most recent change of +$106.50 thousand (+41.68%) on September 30, 2024.
- During the last 3 years, APDN annual accounts receivable has fallen by -$2.44 million (-87.09%).
- APDN annual accounts receivable is now -94.32% below its all-time high of $6.37 million, reached on September 30, 2016.
Performance
APDN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$362.00 K
-$151.90 K-29.56%
September 1, 2024
Summary
- As of February 7, 2025, APDN quarterly accounts receivable is $362.00 thousand, with the most recent change of -$151.90 thousand (-29.56%) on September 1, 2024.
- Over the past year, APDN quarterly accounts receivable has dropped by -$46.90 thousand (-11.47%).
- APDN quarterly accounts receivable is now -94.32% below its all-time high of $6.37 million, reached on September 30, 2016.
Performance
APDN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
APDN Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +41.7% | -11.5% |
3 y3 years | -87.1% | -81.6% |
5 y5 years | -56.9% | -81.6% |
APDN Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -88.2% | +41.7% | -91.1% | +41.7% |
5 y | 5-year | -88.2% | +86.3% | -91.1% | +86.3% |
alltime | all time | -94.3% | +3670.8% | -94.3% | +3670.8% |
Applied DNA Sciences Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $362.00 K(+41.7%) | - |
Sep 2024 | - | $362.00 K(-29.6%) |
Jun 2024 | - | $513.90 K(+25.7%) |
Mar 2024 | - | $408.90 K(-9.3%) |
Dec 2023 | - | $450.80 K(+76.4%) |
Sep 2023 | $255.50 K(-91.7%) | $255.50 K(-62.6%) |
Jun 2023 | - | $682.70 K(-65.3%) |
Mar 2023 | - | $1.97 M(-51.5%) |
Dec 2022 | - | $4.05 M(+32.1%) |
Sep 2022 | $3.07 M(+9.4%) | $3.07 M(+7.3%) |
Jun 2022 | - | $2.86 M(+10.5%) |
Mar 2022 | - | $2.59 M(-32.9%) |
Dec 2021 | - | $3.86 M(+37.6%) |
Sep 2021 | $2.80 M(+1343.1%) | $2.80 M(+280.3%) |
Jun 2021 | - | $737.30 K(-66.3%) |
Mar 2021 | - | $2.19 M(+111.4%) |
Dec 2020 | - | $1.03 M(+432.4%) |
Sep 2020 | $194.30 K(-76.9%) | $194.30 K(-16.0%) |
Jun 2020 | - | $231.20 K(-57.9%) |
Mar 2020 | - | $549.10 K(+100.4%) |
Dec 2019 | - | $274.00 K(-67.4%) |
Sep 2019 | $840.00 K(-43.5%) | $840.00 K(+244.8%) |
Jun 2019 | - | $243.60 K(-23.0%) |
Mar 2019 | - | $316.20 K(-48.6%) |
Dec 2018 | - | $614.80 K(-58.6%) |
Sep 2018 | $1.49 M(-42.6%) | $1.49 M(+5.0%) |
Jun 2018 | - | $1.41 M(-7.3%) |
Mar 2018 | - | $1.53 M(-29.2%) |
Dec 2017 | - | $2.16 M(-16.7%) |
Sep 2017 | $2.59 M(-59.4%) | $2.59 M(-45.5%) |
Jun 2017 | - | $4.75 M(-8.6%) |
Mar 2017 | - | $5.19 M(-15.7%) |
Dec 2016 | - | $6.16 M(-3.4%) |
Sep 2016 | $6.37 M | $6.37 M(+33.0%) |
Jun 2016 | - | $4.79 M(-4.7%) |
Mar 2016 | - | $5.03 M(+28.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | - | $3.92 M(-0.1%) |
Sep 2015 | $3.93 M(+370.7%) | $3.93 M(+89.1%) |
Jun 2015 | - | $2.08 M(+79.1%) |
Mar 2015 | - | $1.16 M(+4.1%) |
Dec 2014 | - | $1.11 M(+33.5%) |
Sep 2014 | $834.80 K(+24.1%) | $834.80 K(+61.1%) |
Jun 2014 | - | $518.30 K(-14.5%) |
Mar 2014 | - | $606.00 K(-19.1%) |
Dec 2013 | - | $749.40 K(+11.4%) |
Sep 2013 | $672.60 K(+126.5%) | $672.60 K(+14.4%) |
Jun 2013 | - | $587.70 K(+44.1%) |
Mar 2013 | - | $407.80 K(+12.7%) |
Dec 2012 | - | $361.80 K(+21.8%) |
Sep 2012 | $297.00 K(+42.4%) | $297.00 K(-32.9%) |
Jun 2012 | - | $442.80 K(+36.8%) |
Mar 2012 | - | $323.60 K(+39.1%) |
Dec 2011 | - | $232.60 K(+11.5%) |
Sep 2011 | $208.60 K(+231.1%) | $208.60 K(+17.3%) |
Jun 2011 | - | $177.80 K(+79.2%) |
Mar 2011 | - | $99.20 K(+58.0%) |
Dec 2010 | - | $62.80 K(-0.3%) |
Sep 2010 | $63.00 K(+33.2%) | $63.00 K(+10.3%) |
Jun 2010 | - | $57.10 K(+60.4%) |
Mar 2010 | - | $35.60 K(+122.5%) |
Dec 2009 | - | $16.00 K(-66.2%) |
Sep 2009 | $47.30 K(-37.0%) | $47.30 K(+188.4%) |
Jun 2009 | - | $16.40 K(-74.3%) |
Mar 2009 | - | $63.80 K(-10.1%) |
Dec 2008 | - | $71.00 K(-5.5%) |
Sep 2008 | $75.10 K(+682.3%) | $75.10 K(-16.1%) |
Jun 2008 | - | $89.50 K(0.0%) |
Mar 2008 | - | $89.50 K(+539.3%) |
Dec 2007 | - | $14.00 K(+45.8%) |
Dec 2006 | - | $9600.00(0.0%) |
Sep 2006 | $9600.00 | $9600.00(-49.2%) |
Jun 2006 | - | $18.90 K |
FAQ
- What is Applied DNA Sciences annual accounts receivable?
- What is the all time high annual accounts receivable for Applied DNA Sciences?
- What is Applied DNA Sciences annual accounts receivable year-on-year change?
- What is Applied DNA Sciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Applied DNA Sciences?
- What is Applied DNA Sciences quarterly accounts receivable year-on-year change?
What is Applied DNA Sciences annual accounts receivable?
The current annual accounts receivable of APDN is $362.00 K
What is the all time high annual accounts receivable for Applied DNA Sciences?
Applied DNA Sciences all-time high annual accounts receivable is $6.37 M
What is Applied DNA Sciences annual accounts receivable year-on-year change?
Over the past year, APDN annual accounts receivable has changed by +$106.50 K (+41.68%)
What is Applied DNA Sciences quarterly accounts receivable?
The current quarterly accounts receivable of APDN is $362.00 K
What is the all time high quarterly accounts receivable for Applied DNA Sciences?
Applied DNA Sciences all-time high quarterly accounts receivable is $6.37 M
What is Applied DNA Sciences quarterly accounts receivable year-on-year change?
Over the past year, APDN quarterly accounts receivable has changed by -$46.90 K (-11.47%)